Company Active LTD

Company profile

Adm Protexin Limited

ADM Protexin | Supplement & Probiotic Manufacturer | UK

ADM Protexin UK Are Dedicated To Producing Innovative, Research Based Live Bacteria Products. Contract Probiotic Manufacturer And White Label Supplier.

CRN
01122942
Founded
1973
Age
52

Overview

Legal name
ADM PROTEXIN LIMITED
Region
Unknown
Registered address
2 NEW BAILEY
6 STANLEY STREET
SALFORD
GREATER MANCHESTER
UNITED KINGDOM
M3 5GS
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Adm Protexin Limited
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events
01 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

15 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

15 Aug
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzMTgyMDc1NWFkaXF6a2N4 | Paper/PDF filed

Published 16 Aug 2024 12:23

16 Jul
1973

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2014
Funded years
2014, 2016, 2017
Age at first award
40 years

Projects

2017 Feasibility Studies Lead participant

Lowering the incidence and death-rate of invasive candidiasis through probiotic bacteria in the gut.

1 Aug 2017 to 31 Jul 2018

Awarded
£80,245
Total cost £133,741

Candida yeast is a common cause of infections of the mouth and the vagina, which are irritating but not life-threatening. However, if Candida enters the bloodstream it causes a dangerous disease known as invasive candidiasis (IC). About one-third of people with IC will die from it (as the Candida infects organs of the body and becomes very difficult to er...

2016 Feasibility Studies

Neutralising the harmful effects of dental biofilms by bacterial replacement therapy

1 Jun 2016 to 31 May 2017

Awarded
£17,887
Total cost £29,811

Dental caries is a widespread oral disease that is costly for health services to treat, and causes pain and loss of teeth to those affected. It is caused by production of acid by oral bacteria in biofilms on the teeth and gums commonly known as dental plaque. Brushing teeth can reduce this problem, but many people do not do so regularly or thoroughly. Thi...

2014 Feasibility Studies

Identification of novel probiotic microorganisms for improved gut function

1 Jan 2014 to 31 Dec 2014

Awarded
£22,413
Total cost £29,884

Probiotics are live microorganisms which when taken in adequate amounts confer health benefits. Changing diets and lifestyles have seen an increase in diet-related health conditions which probiotics acting as novel functional food ingredients can help. There are many probiotic species but the majority of commercial products are restricted to the Lactobaci...

Product types

Feasibility Studies